Decarboxylase inhibitors in the treatment of hypertension∗
- 1 January 1962
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 9 (1) , 116-119
- https://doi.org/10.1016/0002-9149(62)90105-4
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Actions of the Decarboxylase Inhibitor, α-Methyl-3,4-dihydroxyphenylalanine, in the DogNature, 1960
- CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINEAnnals of the New York Academy of Sciences, 1960
- Serotonin Synthesis in Carcinoid PatientsNew England Journal of Medicine, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- Hemmung der Serotoninbildung durch ?-Methyl-DopaNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1958
- Die Beeinflussung der Blutdruckwirkung von Dopa und Dops durch einen Decarboxylase-InhibitorNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1957